Literature DB >> 15672550

Interactions of Abeta(1-40) with glycerophosphocholine and intact erythrocyte membranes: fluorescence and circular dichroism studies.

Pravat K Mandal1, Richard J McClure, Jay W Pettegrew.   

Abstract

Deposition of amyloid beta peptide in human brain in the form of senile plaques is a neuropathological hallmark of Alzheimer's disease (AD). Levels of a phospholipid breakdown product, glycerophosphocholine (GPC), also increase in AD brain. The effect of GPC on amyloid beta(1-40) peptide (Abeta) aggregation in PBS buffer was investigated by circular dichroism and fluoresence spectroscopy; interactions of Abeta and GPC with the intact erythrocyte membrane was examined by fluoresence spectroscopy. Fluorescamine labeled Abeta studies indicate GPC enhances Abeta aggregation. CD spectroscopy reveals that Abeta in the presence of GPC adopts 14% more beta-sheet structure than does Abeta alone. Fluorescamine anisotropy measurements show that GPC and Abeta interact in the phospholipid head-group region of the erythrocyte membrane. In summary, both soluble Abeta and GPC insert into the phospholipid head-group region of the membrane where they interact leading to beta-sheet formation in soluble Abeta which enhances Abeta aggregation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15672550     DOI: 10.1007/s11064-004-7036-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

1.  DICHROWEB: an interactive website for the analysis of protein secondary structure from circular dichroism spectra.

Authors:  A Lobley; L Whitmore; B A Wallace
Journal:  Bioinformatics       Date:  2002-01       Impact factor: 6.937

2.  31P nuclear magnetic resonance study of the brain in Alzheimer's disease.

Authors:  J W Pettegrew; J Moossy; G Withers; D McKeag; K Panchalingam
Journal:  J Neuropathol Exp Neurol       Date:  1988-05       Impact factor: 3.685

3.  Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity.

Authors:  J McLaurin; A Chakrabartty
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

4.  Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

Authors:  L Fratiglioni; L J Launer; K Andersen; M M Breteler; J R Copeland; J F Dartigues; A Lobo; J Martinez-Lage; H Soininen; A Hofman
Journal:  Neurology       Date:  2000       Impact factor: 9.910

5.  31P magnetic resonance spectroscopy in Alzheimer's and Pick's disease.

Authors:  C D Smith; L G Gallenstein; W J Layton; R J Kryscio; W R Markesbery
Journal:  Neurobiol Aging       Date:  1993 Jan-Feb       Impact factor: 4.673

6.  Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid.

Authors:  Atsuko Kakio; Sei-ichi Nishimoto; Katsuhiko Yanagisawa; Yasunori Kozutsumi; Katsumi Matsuzaki
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

7.  Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease.

Authors:  J W Pettegrew; K Panchalingam; J Moossy; J Martinez; G Rao; F Boller
Journal:  Arch Neurol       Date:  1988-10

8.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

9.  Red cell perturbations by amyloid beta-protein.

Authors:  Rajadas Jayakumar; John W Kusiak; Francis J Chrest; Andrew A Demehin; Jayaraman Murali; Robert P Wersto; Enika Nagababu; Lukebabu Ravi; Joseph M Rifkind
Journal:  Biochim Biophys Acta       Date:  2003-06-20

Review 10.  Perturbed signal transduction in neurodegenerative disorders involving aberrant protein aggregation.

Authors:  Mark P Mattson; Michael Sherman
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

View more
  4 in total

Review 1.  Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.

Authors:  Vijayaraghavan Rangachari; Dexter N Dean; Pratip Rana; Ashwin Vaidya; Preetam Ghosh
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-09       Impact factor: 3.747

2.  Non-esterified fatty acids generate distinct low-molecular weight amyloid-β (Aβ42) oligomers along pathway different from fibril formation.

Authors:  Amit Kumar; Rebekah L Bullard; Pritesh Patel; Lea C Paslay; Dipti Singh; Ewa A Bienkiewicz; Sarah E Morgan; Vijayaraghavan Rangachari
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

3.  Fatty Acid Concentration and Phase Transitions Modulate Aβ Aggregation Pathways.

Authors:  Pratip Rana; Dexter N Dean; Edward D Steen; Ashwin Vaidya; Vijayaraghavan Rangachari; Preetam Ghosh
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

4.  MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer's disease pathogenesis.

Authors:  Jiqing Cao; Min Huang; Lei Guo; Li Zhu; Jianwei Hou; Larry Zhang; Adriana Pero; Sabrina Ng; Farida El Gaamouch; Gregory Elder; Mary Sano; Alison Goate; Julia Tcw; Vahram Haroutunian; Bin Zhang; Dongming Cai
Journal:  Mol Psychiatry       Date:  2020-07-06       Impact factor: 15.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.